Rare diseases
Investigational molecules
Locations
A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
ItalyA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
ItalyStudy of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments
ItalyStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
ItalyStudy of daratumumab, teclistamab and talquetamab combination treatment for frail patients with newly diagnosed multiple myeloma
ItalyStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
ItalyStudy of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer
ItalyStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
ItalyStudy of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment
ItalyStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
ItalyLong-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031
ItalyStudy of Nirogacestat in adult premenopausal women with desmoid tumors and aggressive fibromatosis to evaluate ovarian function recovery
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
